Track topics on Twitter Track topics that are important to you
Deals and Financings
- aTyr Pharma, a public San Diego-
- Akeso Biopharma of Zhongshan closed a $45 million B round, led by the GTJA Investment Group, to develop its antibody portfolio;
- Fosun Pharma paid $40 million to acquire a 65% stake in Shanghai SinoMedCare Biotech, a medical marketing company focused on tier 3
- Distinct Healthcare of
- Shuidi, a China crowdfunding platform aimed at helping people pay for healthcare, raised $24 million in a Series A round led by Tencent Holdings;
Trials and Approvals
- iCAD, a
Stock Symbols: (SHZ: 000710) (F: MGN) (NSDQ: LIFE) (SHA: 600196; HK: 2196) (NSDQ: ICAD)
Share this with colleagues:
Original Article: Week in Review: This Week's China Pharma Deals Top $1 BillionNEXT ARTICLE
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...